This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
WellCare (WCG) Buys Aetna's Medicare Assets to Fuel Growth
by Zacks Equity Research
WellCare's (WCG) purchase of Medicare business of Aetna should lead to long-term growth.
Near-Term Outlook for Medical Information Systems Industry
by Zacks Equity Research
The wave of digital transition is helping companies in the Zacks Medical Info Systems industry to create opportunities for investors.
The Zacks Analyst Blog Highlights: Anthem, HCA, Dr. Reddy's and UnitedHealth
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Anthem, HCA, Dr. Reddy's and UnitedHealth
Healthcare Takes Wall Street Lead: 4 Picks
by Tirthankar Chakraborty
Continuous innovation and research in the field of biotechnology and an increasingly aged population in the United States are helping whet appetite for healthcare shares.
The Zacks Analyst Blog Highlights: General Motors, Boeing, Microsoft, Merck and UnitedHealth
by Zacks Equity Research
The Zacks Analyst Blog Highlights: General Motors, Boeing, Microsoft, Merck and UnitedHealth
The Last Week of November Yields a Strong Market Rally
by David Borun
Dovish Fed commentary and progress on trade issues send the US equity markets sharply higher
The Zacks Analyst Blog Highlights: Boeing, Merck, Microsoft, UnitedHealth and American Express
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Boeing, Merck, Microsoft, UnitedHealth and American Express
Dow 30 Stock Roundup: BA's $383M Modification Contract, MSFT's Army Contract
by Swarup Gupta
The Dow recovered from two weeks of losses to post strong gains this week.
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $282.55, marking a +0.57% move from the previous day.
Humana to Gain from Share Buyback, Raise Membership Outlook
by Zacks Equity Research
Humana (HUM) announces accelerated share buyback and gears up for increased Medicare Advantage membership.
6 Reasons Why You Should Add Anthem Stock to Your Portfolio
by Zacks Equity Research
Riding high on robust results, strong capital efficiency and buyouts; Anthem (ANTM) holds great prospects to reap returns for investors.
UnitedHealth (UNH) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
UnitedHealth (UNH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Dow Records Highest Single Day Gain in 8 Months: 5 Picks
by Nalak Das
Despite stock market mayhem, fundamentals of the U.S. economy remain strong which will help sustain the rally.
UnitedHealth Gains on Strong 2019 Outlook, Acquisition News
by Zacks Equity Research
UnitedHealth's (UNH) strong 2019 guidance boosts investors' confidence in it.
The Zacks Analyst Blog Highlights: JPMorgan, Procter & Gamble, UnitedHealth, McDonald's and Philip Morris
by Zacks Equity Research
The Zacks Analyst Blog Highlights: JPMorgan, Procter & Gamble, UnitedHealth, McDonald's and Philip Morris
Top Stock Reports for JPMorgan, Procter & Gamble and UnitedHealth
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including JPMorgan (JPM), Procter & Gamble (PG) and UnitedHealth (UNH)
Zacks.com highlights: BJ's Restaurants, CBRE Group, Dave & Buster's Entertainment, UnitedHealth Group and Boeing
by Zacks Equity Research
Zacks.com highlights: BJ's Restaurants, CBRE Group, Dave & Buster's Entertainment, UnitedHealth Group and Boeing
UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $266.05, marking a -1.87% move from the previous day.
5 Stocks That Sport Remarkable Interest Coverage Ratio
by Zacks Equity Research
Interest Coverage Ratio is used to determine how effectively a company can pay the interest charged on its debt.
Stocks Stage a Late Rally to Take Some of the Sting Out of a Losing Week
by David Borun
With interest rates declining, investors turn their focus to Brexit and China trade negotiations
Why UnitedHealth (UNH) is an Attractive Stock to Own Now
by Zacks Equity Research
Medicaid expansion, upward revision in earnings guidance and inherent business strength make UnitedHealth (UNH) an attractive bet.
UnitedHealth (UNH) Down 0.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
UnitedHealth (UNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Humana, PIP Collaborate on Better HealthCare for MA Members
by Zacks Equity Research
Humana (HUM) enters into an agreement with Premier Independent Physicians to provide Medicare Advantage Members in Dallas-Fort Worth Metro with a better patient experience.
Here's What Makes Molina Healthcare (MOH) an Attractive Bet
by Zacks Equity Research
Favorable changes across the industry and inside the company poise Molina Healthcare (MOH) for strong growth.
Near-Term Outlook for Health Maintenance Organization Industry
by Zacks Equity Research
Retiring baby boomer population, new streams of revenues and consolidation paint a bright picture for the HMO industry.